Alzheimer's β-amyloid peptide 1-42 induces a phagocytic response in murine microglia

Journal of Neurochemistry

Volumn 71, Issue 5, 1998, Pages 2123-2131

  Kopec, Karla K ^a   Carroll, Richard T ^a  

^a PFIZER INC   (United States)

Author keywords

Acetylated low density lipoproteins; Microglia; Microspheres; Phagocytosis; Zymosan; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; MICROGLIA; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0031753157     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71052123.x     Document Type: Article

References (59)

1. Ard M. D., Cole G. M., Wei J., Mehrle A. P., and Fratkin J. D. (1996) Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J. Neurosci. Res. 43, 190-202.
2. Bitting L., Naidu A., Cordell B., and Murphy G. M. (1996) Beta-amyloid peptide secretion by a microglial cell line is induced by beta-amyloid-(25-35) and lipopolysaccharide. J. Biol. Chem. 271, 16084-16089.
3. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., and Bistoni F. (1990) Immortalization of murine microglial cells by a v-raf/ v-myc carrying retrovirus. J. Neuroimmunol. 27, 229-237.
4. Bonaiuto C., McDonald P. P., Rossi F., and Cassatella M. A. (1997) Activation of nuclear factor-κB by β-amyloid peptides and interferon-γ in murine microglia. J. Neuroimmunol. 77, 51-56.
5. Brachova L., Lue L. F., Schultz J., El Rashidy T., and Rogers J. (1993) Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease. Mol. Brain Rex. 18, 329-334.
6. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffe E. A., Gandy S. E., and Greengard P. (1992) Cholinergic agonists and interleukin-1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89, 10075-10078.
7. Castillo G. M., Ngo C., Cummings J., Wight T. N., and Snow A. D. (1997) Perlecan binds to the β-amyloid proteins (Aβ) of Alzheimer's disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability. J. Neurochem. 69, 2452-2465.
8. Chen S., Frederickson R. C. A., and Brunden K. R. (1996) Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches. Neurobiol. Aging 17, 781-787.
9. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., and Selkoe D. J. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672-674.
10. Cummings B. J., Pike C. J., Shankle R., and Cotman C. W. (1996) β-Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging 17, 921-933.
11. Daum T. and Rohrbach M. S. (1992) Zymosan induces selective release of arachidonic acid from rabbit alveolar macrophages via stimulation of a beta-glucan receptor. FEBS Lett. 309, 119-122.
12. Davis J. B., McMurray H. F., and Schubert D. (1992) The amyloid beta protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem. Biophys. Res. Commun. 189, 1096-1100.
13. El-Agnaf O. M. A., Irvine G. B., and Guthrie D. J. S. (1997) Conformations of β-amyloid in solution. J. Neurochem. 68, 437-439.
14. El Khoury J., Hickman S. E., Thomas C. A., Cao L., Silverstein S. C., and Loike J. D. (1996) Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382, 716-719.
15. Elstad M. R., La Pine T. R., Cowley F. S., McEver R. P., McIntyre T. M., Prescott S. M., and Zimmerman G. A. (1995) P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes. J. Immunol. 155, 2109-2122.
16. Finch C. E. and Marchalonis J. J. (1996) Evolutionary perspectives on amyloid and inflammatory features of Alzheimer's disease. Neurobiol. Aging 17, 809-815.
17. Frackowiak J., Wisniewski H. M., Wegiel J., Merz G. S., Iqbal I., and Wang K. C. (1992) Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropathol. 84, 225-233.
18. Frautschy S. A., Yang F., Irrizarry M., Hyman B., Saido T. C., Hsiao K., and Cole G. (1998) Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152, 307-317.
19. Frederickson R. C. A. and Brunden K. R. (1994) New opportunities in AD research - roles of immunoinflammatory responses and glia. Alzheimer Dis. Assoc. Disord. 8, 159-164.
20. Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
21. Goodwin J. L., Uemura E., and Cunnick J. E. (1995) Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ. Brain Res. 692, 207-214.
22. Griess J. P. (1864) On a new series of bodies in which nitrogen is substituted for hydrogen. Philos. Trans. R. Soc. Lond. 154, 667-731.
23. Griffin W. S. T., Sheng J. G., Roberts G. W., and Mrak R. E. (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54, 276-281.
24. Haass C. and Selkoe D. J. (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75, 1039-1042.
25. Hardy J. and Allsop D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12, 383-388.
26. Hoke A., Canning D. R., Malemud C. J., and Silver J. (1994) Regional differences in reactive gliosis induced by substrate-bound beta-amyloid. Exp. Neurol. 130, 56-66.
27. Ishii T. and Haga S. (1984) Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol. 63, 296-300.
28. Klegaris A., Walker D. G., and McGeer P. L. (1997) Interaction of Alzheimer β-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α. Brain Res. 747, 114-121.
29. Lemere C. A., Lopera F., Kosik K. S., Lendon C. L., Ossa J., Saido T. C., Yamaguchi H., Ruiz A., Martinez A. O., Madrigal L., Hincapie L., Arango J. C., Anthony D. C., Koo C. H., Goate A., and Selkoe D. J. (1996) The E280A presenilin 1 Alzheimer mutation produced Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2, 1146-1150.
30. LeVine H. (1993) Thioflavin T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2, 404-410.
31. Lorton D., Kocsis J. M., King L., Madden K., and Brunden K. R. (1996) Beta-amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes. J. Neuroimmunol. 67, 21-29.
32. Lougheed M., Lum C. M., Ling W., Suzuki H., Kodama T., and Steinbrecher U. (1997) High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J. Biol. Chem. 272, 12938-12944.
33. Mackenzie I. R. A., Hao C., and Munoz D. G. (1995) Role of microglia in senile plaque formation. Neurobiol. Aging 16, 797-804.
34. Masayuki I., Sunamoto M., Ohnishi K., and Ichimori Y. (1996) β-Amyloid protein dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res. 720, 93-100.
35. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
36. McDonald D. R., Brunden K. R., and Landreth G. E. (1997) Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17, 2284-2294.
37. McDonald D. R., Bamberger M. E., Combs C. K., and Landreth G. E. (1998) β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP-1 monocytes. J. Neurosci. 18, 4451-4460.
38. Meda L., Bonaiuto C., Szendrei G. I., Ceska M., Rossi F., and Cassatella M. A. (1995a) β-Amyloid (25-35) induces the production of interleukin-8 from human monocytes. J. Neuroimmunol. 59, 29-33.
39. Meda L., Cassatella M. A., Szendrei G. I., Otvos L., Baron P., Villalba M., Ferrari D., and Rossi F. (1995b) Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374, 647-650.
40. Paresce D. M., Ghosh R. N., and Maxfield F. R. (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 17, 553-565.
41. Paresce D. M., Chung H., and Maxfield F. R. (1997) Slow degradation of aggregates of the Alzheimer's disease amyloid β-protein by microglial cells. J. Cell Biol. 272, 29390-29397.
42. Qiu W. Q., Ye Z., Kholodenko D., Seubert P., and Selkoe D. J. (1997) Degradation of amyloid β-protein by a metalloprotease secreted by microglia and other neural and non-neural cells. J. Biol. Chem. 272, 6641-6646.
43. Rogers J., Cooper N. R., Webster S., Schultz J., McGeer P. L., Styren S. D., Civin W. H., Brachova L., Bradt B., Ward P., and Lieberburg I. (1992) Complement activation by β-amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 89, 10016-10020.
44. Rogers J., Webster S., Lue L.-F., Brachova L., Civin W. H., Emmerling M., Shivers B., Walker D., and McGeer P. (1996) Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17, 681-686.
45. Sadler I. I. J., Smith D. W., Shearman M. S., Ragan C. I., Tailor V. J., and Pollack S. J. (1995) Sulfated compounds attenuate β-amyloid toxicity by inhibiting its association with cells. Neuroreport 7, 49-53.
46. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
47. Schmidt H. H. H. W., Warner T. D., Nakane M., Forstermann U., and Murad F. (1992) Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol. Pharmacol. 41, 615-624.
48. Shaffer L. M., Dority M. D., Gupta-Bansai R., Frederickson R. C. A., Younkin S. G., and Branden K. R. (1995) Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol. Aging 16, 737-745.
49. Shalit F., Sredni B., Rosenblatt-Bin H., Kazimirsky G., Brodie C., and Huberman M. (1997) β-Amyloid peptide induces tumor necrosis factor-α and nitric oxide production in murine macrophage cultures. Neuroreport 8, 3577-3580.
50. Sheng J. G., Mrak R. E., and Griffin W. S. T. (1994) S100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39, 398-404.
51. Sheng J. G., Ito K., Skinner R. D., Mrak R. E., Rovnaghi C. R., Van Eldik L. J., and Griffin W. S. T. (1996) In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 17, 761-766.
52. Sheng J. G., Mrak R. E., and Griffin W. S. T. (1997) Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. 94, 1-5.
53. Snow A. D., Sekiguchi R., Nochlin D., Kalaria R. N., and Kimata K. (1994) Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not in cerebellum of Alzheimer's disease brain. Am. J. Pathol. 144, 337-347.
54. Steinkamp J. A., Wilson J. S., Saunders G. C., and Stewart C. C. (1982) Phagocytosis: flow cytometric quantitation with fluorescent microspheres. Science 215, 64-66.
55. Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L. J., Eckman C., Golde T. E., and Younkin S. G. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264, 1336-1340.
56. Vlassara H., Brownlee M., and Cerami A. (1985) High-affinity receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc. Natl. Acad. Sci. USA 82, 5588-5592.
57. von Zahn J., Moller T., Kettenmann H., and Nolte C. (1997) Microglial phagocytosis is modulated by pro-and anti-inflammatory cytokines. Neuroreport 8, 3851-3856.
58. Wisniewski H. M., Bancher C., Barcikowska M., Wen G. Y., and Gurie J. (1989) Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol. (Berl.) 78, 337-347.
59. Young I. D., Willmer J. P., and Kisilevsky R. (1989) The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis. Acta Neuropathol. (Berl.) 78, 202-209.